About Ascendance Biotechnology
Ascendance Biotechnology is a company based in Medford (United States) founded in 2015 was acquired by BioIVT in March 2018.. Ascendance Biotechnology has raised $880 thousand across 2 funding rounds from investors including BioIVT. The company has 11 employees as of December 31, 2017. Ascendance Biotechnology operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Medford, United States
- Employees 11 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ascendance Biotechnology
Ascendance Biotechnology has successfully raised a total of $880K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $230 thousand completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $230,000
-
First Round
First Round
(21 Dec 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2016 | Amount | Seed - Ascendance Biotechnology | Valuation |
investors |
|
| Dec, 2015 | Amount | Seed - Ascendance Biotechnology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ascendance Biotechnology
Ascendance Biotechnology has secured backing from 1 investor. Prominent investors backing the company include BioIVT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of in vitro diagnostic products and assay services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ascendance Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ascendance Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ascendance Biotechnology Comparisons
Competitors of Ascendance Biotechnology
Ascendance Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ascendance Biotechnology
When was Ascendance Biotechnology founded?
Ascendance Biotechnology was founded in 2015.
Where is Ascendance Biotechnology located?
Ascendance Biotechnology is headquartered in Medford, United States. It is registered at Medford, Oregon, United States.
Is Ascendance Biotechnology a funded company?
Ascendance Biotechnology is a funded company, having raised a total of $880K across 2 funding rounds to date. The company's 1st funding round was a Seed of $650K, raised on Dec 21, 2015.
How many employees does Ascendance Biotechnology have?
As of Dec 31, 2017, the latest employee count at Ascendance Biotechnology is 11.
What does Ascendance Biotechnology do?
Ascendance Biotechnology was established in 2015 through the consolidation of assets from Hepregen Corporation and ESI BIO, operating as a transnational entity in the biotechnology sector. Cell-based assay products, including HepatoPac and HepatoMune micro-liver platforms, are manufactured in Medford, United States, alongside contract services for pharmaceutical and diagnostic applications. Stem cell lines, progenitor cells, hydrogel kits, antibodies, and small molecules from the ESI BIO line are also distributed.
Who are the top competitors of Ascendance Biotechnology?
Ascendance Biotechnology's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Ascendance Biotechnology's investors?
Ascendance Biotechnology has 1 investor. Key investors include BioIVT.